Deal for PBI1402 this weekWhy did they give Pierre Laurin $400k upfront royalties on PBI1402 to "clean this up." Why now when they are pulling all of the 4050 indications from clinical trial planning? Is this not just a little suspicious that they would pay Pierre Laurin upfront cash on a deal for a failed drug? Is Thomvest bribing him so he doesnt talk in lawsuit? Any one a reason why this move was necessary now? It just doesn't make too much sense except cleaning up company IP for private sale after it runs out of money. The lack of an official press release regarding this move explains anything about it makes it even more suspicious. I guess Pritchard has to do something with his time. They gave up conference calls for 15 min each time. Does it seem like they are intentionally tanking this company for Thomvests benefit?